BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 28482033)

  • 1. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
    Sekihara K; Hishida T; Yoshida J; Oki T; Omori T; Katsumata S; Ueda T; Miyoshi T; Goto M; Nakasone S; Ichikawa T; Matsuzawa R; Aokage K; Goto K; Tsuboi M
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):522-528. PubMed ID: 28482033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected.
    Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Kawamura M
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):14-20. PubMed ID: 25878187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival†.
    Hishida T; Yoshida J; Aokage K; Nagai K; Tsuboi M
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):847-53. PubMed ID: 26201958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and late recurrence after intentional limited resection for cT1aN0M0, non-small cell lung cancer: from a multi-institutional, retrospective analysis in Japan.
    Matsumura Y; Yano M; Yoshida J; Koike T; Kameyama K; Shimamoto A; Nishio W; Yoshimoto K; Utsumi T; Shiina T; Watanabe A; Yamato Y; Watanabe T; Takahashi Y; Sonobe M; Kuroda H; Oda M; Inoue M; Tanahashi M; Adachi H; Saito M; Hayashi M; Otsuka H; Mizobuchi T; Moriya Y; Takahashi M; Nishikawa S; Suzuki H;
    Interact Cardiovasc Thorac Surg; 2016 Sep; 23(3):444-9. PubMed ID: 27226401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and prognostic factors of non-small cell lung cancer patients with postoperative locoregional recurrence treated with radical radiotherapy.
    Ma L; Qiu B; Zhang J; Li QW; Wang B; Zhang XH; Qiang MY; Chen ZL; Guo SP; Liu H
    Chin J Cancer; 2017 Dec; 36(1):93. PubMed ID: 29228994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.
    Takenaka T; Takenoyama M; Yamaguchi M; Toyozawa R; Inamasu E; Kojo M; Toyokawa G; Yoshida T; Shiraishi Y; Morodomi Y; Hirai F; Taguchi K; Shimokawa M; Seto T; Ichinose Y
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):550-5. PubMed ID: 24894095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical outcome of wide wedge resection in poor-risk patients with clinical-N0 non-small cell lung cancer.
    Tsunezuka H; Kato D; Okada S; Furuya T; Shimada J; Inoue M
    Gen Thorac Cardiovasc Surg; 2017 Oct; 65(10):581-586. PubMed ID: 28748318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection.
    Jeon JH; Kang CH; Kim HS; Seong YW; Park IK; Kim YT
    Eur J Cardiothorac Surg; 2015 Mar; 47(3):556-62. PubMed ID: 24760387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
    Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
    J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors for Survival After Recurrence in Patients With Completely Resected Lung Adenocarcinoma: Important Roles of Epidermal Growth Factor Receptor Mutation Status and the Current Staging System.
    Kudo Y; Shimada Y; Saji H; Kato Y; Yoshida K; Matsubayashi J; Nagase S; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Clin Lung Cancer; 2015 Nov; 16(6):e213-21. PubMed ID: 25986624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer.
    Cho S; Yum S; Kim K; Jheon S
    Eur J Cardiothorac Surg; 2018 Sep; 54(3):554-559. PubMed ID: 29490049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer.
    Maurizi G; D'Andrilli A; Ciccone AM; Ibrahim M; Andreetti C; Tierno S; Poggi C; Menna C; Venuta F; Rendina EA
    Ann Thorac Surg; 2015 Sep; 100(3):918-24; discussion 924-5. PubMed ID: 26209486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer.
    Takenaka T; Inamasu E; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Yamaguchi M; Seto T; Takenoyama M; Ichinose Y
    Surg Today; 2016 Apr; 46(4):430-6. PubMed ID: 26070907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer.
    Song IH; Yeom SW; Heo S; Choi WS; Yang HC; Jheon S; Kim K; Cho S
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):262-7. PubMed ID: 23811122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer.
    Wang C; Wu Y; Shao J; Liu D; Li W
    BMC Cancer; 2020 Feb; 20(1):150. PubMed ID: 32093621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-Assessment of Intentional Extended Segmentectomy for Clinical T1aN0 Non-Small Cell Lung Cancer.
    Nishio W; Yoshimura M; Maniwa Y; Kitamura Y; Tane K; Takenaka D; Adachi S
    Ann Thorac Surg; 2016 Nov; 102(5):1702-1710. PubMed ID: 27526651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and the significance of treatment after recurrence in completely resected stage I non-small cell lung cancer.
    Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Chest; 2013 Jun; 143(6):1626-1634. PubMed ID: 23348916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
    Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
    Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.